Eur Rev Med Pharmacol Sci 2015; 19 (19): 3593-3604

Overexpression of miR-98 inhibits cell invasion in glioma cell lines via downregulation of IKKε

Y.-H. Fan, M.-H. Ye, L. Wu, S.-G. Lv, M.-J. Wu, B. Xiao, C.-C. Liao, Q.-K. Ji, Y. Chai, X.-G. Zhu

Department of Neurosurgery, The Second Affiliated Hospital, Nanchang University, Nanchang, Jiangxi, People’s Republic of China. zxg2008vip@163.com


OBJECTIVE: MicroRNAs (miRNAs) function as negative regulators for the expression of genes involved in cancer metastasis. The aim of this study was to investigate the potential role of miR-98 in gliomas and validate its regulatory mechanism.

PATIENTS AND METHODS: Cell viability assays are used to measure proliferation of cell. mRNA expression is measured by qRT-PCR. Western blot analysis is used to measure protein expression.

RESULTS: Functional studies showed that miR-98 overexpression inhibited glioma migration and invasion, but had no effect on the cell viability. An enhanced green fluorescent protein reporter assay, quantitative RT-PCR, and a western blot analysis confirmed that miR-98 suppressed the expression of IκB kinase (IKKε) by directly targeting its 3′-untranslated region, also, the NF-κB p65 nuclear translocation and matrix metalloproteinase (MMP)-9 expression were significantly arrested in glioma cells treated with miR-98 mimics. Accordingly, the overexpression of IKKε or NF-κB p65 can restore cell migration and invasion after being inhibited by miR-98, and can restore NF-κB p65 nuclear translocation as well as increase MMP-9 expression.

CONCLUSIONS: These findings demonstrated that miR-98 functions as a tumor suppressor in gliomas. Furthermore, miR-98 may act as a potential therapeutic biomarker for glioma patients.

Free PDF Download

To cite this article

Y.-H. Fan, M.-H. Ye, L. Wu, S.-G. Lv, M.-J. Wu, B. Xiao, C.-C. Liao, Q.-K. Ji, Y. Chai, X.-G. Zhu
Overexpression of miR-98 inhibits cell invasion in glioma cell lines via downregulation of IKKε

Eur Rev Med Pharmacol Sci
Year: 2015
Vol. 19 - N. 19
Pages: 3593-3604